0001415889-14-000788.txt : 20140311
0001415889-14-000788.hdr.sgml : 20140311
20140311171521
ACCESSION NUMBER: 0001415889-14-000788
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140307
FILED AS OF DATE: 20140311
DATE AS OF CHANGE: 20140311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moore Terrence O
CENTRAL INDEX KEY: 0001454276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 14685108
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-03112014_020312.xml
X0306
4
2014-03-07
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001454276
Moore Terrence O
11085 TORREYANA ROAD #100
SAN DIEGO
CA
92121
false
true
false
false
EVP, CHIEF COMMERCIAL OFFICER
Stock Option (right to buy)
27.20
2014-03-07
4
A
0
35000
0
A
2024-03-06
Common Stock
35000
35000
D
25% of the shares subject to the Stock Option vest and become exercisable on March 7, 2015. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
/s/ Glenn F. Baity, Attorney-in-Fact
2014-03-11